Literature DB >> 33479092

Images of the month: Gliptin-induced bullous pemphigoid.

Oluwafikunayo Orekoya1, Ian H Coulson2.   

Abstract

Keywords:  DPP4-inhibitors; bullous pemphigoid; dermatology; gliptin,

Mesh：

Substances：

Year:  2021        PMID： 33479092      PMCID： PMC7850176          DOI： 10.7861/clinmed.2020-0825

Source DB:  PubMed          Journal:  Clin Med (Lond)        ISSN： 1470-2118            Impact factor:   2.659


× No keyword cloud information.
  5 in total

1.  Guidelines for the management of bullous pemphigoid.

Authors:  F Wojnarowska; G Kirtschig; A S Highet; V A Venning; N P Khumalo
Journal:  Br J Dermatol       Date:  2002-08       Impact factor: 9.302

Review 2.  Drug-induced pemphigoid: a review of the literature.

Authors:  P G Stavropoulos; E Soura; C Antoniou
Journal:  J Eur Acad Dermatol Venereol       Date:  2014-01-10       Impact factor: 6.166

3.  Dipeptidyl peptidase IV inhibitors, a risk factor for bullous pemphigoid: Retrospective multicenter case-control study from France and Switzerland.

Authors:  Michael Benzaquen; Luca Borradori; Philippe Berbis; Simone Cazzaniga; René Valero; Marie-Aleth Richard; Laurence Feldmeyer
Journal:  J Am Acad Dermatol       Date:  2017-12-21       Impact factor: 11.527

4.  Higher Frequency of Dipeptidyl Peptidase-4 Inhibitor Intake in Bullous Pemphigoid Patients than in the French General Population.

Authors:  Marthe Plaquevent; Florence Tétart; Laurence Fardet; Saskia Ingen-Housz-Oro; Laurence Valeyrie-Allanore; Philippe Bernard; Vivien Hebert; Aude Roussel; Martine Avenel-Audran; Guillaume Chaby; Michel D'Incan; Marie-Christine Ferrier-Le-Bouedec; Sophie Duvert-Lehembre; Catherine Picard-Dahan; Geraldine Jeudy; Evelyne Collet; Bruno Labeille; Cécile Morice; Marie-Aleth Richard; Isabelle Bourgault-Villada; Noémie Litrowski; Corina Bara; Emmanuel Mahe; Catherine Prost-Squarcioni; Marina Alexandre; Gaelle Quereux; Claire Bernier; Angèle Soria; Domitille Thomas-Beaulieu; Christine Pauwels; Olivier Dereure; Jacques Benichou; Pascal Joly
Journal:  J Invest Dermatol       Date:  2018-12-10       Impact factor: 8.551

Review 5.  Dipeptidyl Peptidase-4 Inhibitor-Associated Bullous Pemphigoid.

Authors:  Kaisa Tasanen; Outi Varpuluoma; Wataru Nishie
Journal:  Front Immunol       Date:  2019-06-04       Impact factor: 8.786
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.